Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 17979800)

  • 1. Sphingolipid signaling pathways as potential therapeutic targets in gliomas.
    Van Brocklyn JR
    Mini Rev Med Chem; 2007 Oct; 7(10):984-90. PubMed ID: 17979800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-Phosphate.
    Hawkins CC; Ali T; Ramanadham S; Hjelmeland AB
    Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32977496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells.
    Marfia G; Campanella R; Navone SE; Di Vito C; Riccitelli E; Hadi LA; Bornati A; de Rezende G; Giussani P; Tringali C; Viani P; Rampini P; Alessandri G; Parati E; Riboni L
    Glia; 2014 Dec; 62(12):1968-81. PubMed ID: 25042636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine Kinase Inhibitors as Maintenance Therapy of Glioblastoma After Ceramide-Induced Response.
    Sordillo LA; Sordillo PP; Helson L
    Anticancer Res; 2016 May; 36(5):2085-95. PubMed ID: 27127108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis.
    Abuhusain HJ; Matin A; Qiao Q; Shen H; Kain N; Day BW; Stringer BW; Daniels B; Laaksonen MA; Teo C; McDonald KL; Don AS
    J Biol Chem; 2013 Dec; 288(52):37355-64. PubMed ID: 24265321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of S1P metabolizing enzymes and receptors correlate with survival time and regulate cell migration in glioblastoma multiforme.
    Bien-Möller S; Lange S; Holm T; Böhm A; Paland H; Küpper J; Herzog S; Weitmann K; Havemann C; Vogelgesang S; Marx S; Hoffmann W; Schroeder HW; Rauch BH
    Oncotarget; 2016 Mar; 7(11):13031-46. PubMed ID: 26887055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death.
    Van Brocklyn JR; Williams JB
    Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):26-36. PubMed ID: 22613819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
    Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
    Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.
    Huwiler A; Pfeilschifter J
    Curr Pharm Des; 2006; 12(35):4625-35. PubMed ID: 17168766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
    Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
    Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingolipids in neurodegeneration (with focus on ceramide and S1P).
    Wang G; Bieberich E
    Adv Biol Regul; 2018 Dec; 70():51-64. PubMed ID: 30287225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipid metabolizing enzymes as novel therapeutic targets.
    Billich A; Baumruker T
    Subcell Biochem; 2008; 49():487-522. PubMed ID: 18751924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
    Tabuchi K; Hara A
    Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders.
    Czubowicz K; Jęśko H; Wencel P; Lukiw WJ; Strosznajder RP
    Mol Neurobiol; 2019 Aug; 56(8):5436-5455. PubMed ID: 30612333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Sphingolipid Rheostat in Gliomas.
    Zaibaq F; Dowdy T; Larion M
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine 1-phosphate (S1P) signaling in glioblastoma multiforme-A systematic review.
    Mahajan-Thakur S; Bien-Möller S; Marx S; Schroeder H; Rauch BH
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29149079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipids in macroautophagy.
    Lavieu G; Scarlatti F; Sala G; Carpentier S; Levade T; Ghidoni R; Botti J; Codogno P
    Methods Mol Biol; 2008; 445():159-73. PubMed ID: 18425450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling.
    Chalfant CE; Spiegel S
    J Cell Sci; 2005 Oct; 118(Pt 20):4605-12. PubMed ID: 16219683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
    Selvam SP; Ogretmen B
    Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of bioactive sphingolipids in physiology and pathology.
    Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
    Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.